Insomnia News and Research

Latest Insomnia News and Research

Addressing sleep hygiene prior to CPAP initiation may help improve adherence

A new study suggests that regularity of bedtime prior to initiation of continuous positive airway pressure therapy is an important factor that may influence treatment compliance in adults with obstructive sleep apnea.

8 May 2013

Study shows association between diet, sleepiness and alertness

A new study suggests that your level of sleepiness or alertness during the day may be related to the type of food that you eat.

8 May 2013

Restless legs syndrome and insomnia: a possible explanation

Johns Hopkins researchers believe they may have discovered an explanation for the sleepless nights associated with restless legs syndrome (RLS), a symptom that persists even when the disruptive, overwhelming nocturnal urge to move the legs is treated successfully with medication.

7 May 2013

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

A new report shows that the number of emergency department visits involving adverse reactions to the sleep medication zolpidem rose nearly 220 percent from 6,111 visits in 2005 to 19,487 visits in 2010.

2 May 2013

Cognitive training improves insomnia sleep quality

Older adults with insomnia could benefit from computerized cognitive training, which researchers have found helps in the initiation and maintenance of sleep.

30 Apr 2013

Hostility linked to poor sleep quality

People with high levels of hostility are like to have poor sleep quality, suggests research showing a robust link between the two features.

29 Apr 2013

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Results from "Aviator," AbbVie's phase IIb clinical trial of its investigational direct-acting antivirals for the treatment of hepatitis C virus infection, continue to demonstrate high sustained viral response rates against genotype 1 HCV, across patient types.

24 Apr 2013

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc. announced today that the United States Food and Drug Administration has approved Sucampo's supplemental new drug application for AMITIZA (lubiprostone) (24 mcg twice daily) as the first and only oral medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.

24 Apr 2013

New data on Enanta's lead HCV protease inhibitor to be presented at International Liver Congress

Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that new Phase 2b data related to ABT-450, Enanta's lead HCV protease inhibitor identified in its ongoing collaboration with AbbVie, as well as new preclinical data on Enanta's proprietary cyclophilin inhibitor, EDP-546, will be presented at the International Liver Congress, which is the 48th Annual Meeting of the European Association for the Study of the Liver taking place in Amsterdam April 24-28, 2013.

23 Apr 2013

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.

23 Apr 2013

Researchers suggest two days of staging at moderate altitude reduces acute mountain sickness

Afghanistan's geography is dominated by a collection of craggy peaks, the highest-a mountain known as Noshaq-has been measured to 7,492 meters. Consequently, the soldiers on duty in this mountainous terrain must often ascend to great heights as part of their duty.

22 Apr 2013

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics, Inc. today announced that a proof-of-concept trial found dalfampridine extended release tablets, marketed as AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, improved walking in people with post-stroke deficits.

16 Apr 2013

New research shows effects of long-term use of opioid therapy

Half of patients on high-dose, long-term opioid therapy had hormonal disturbances or signs of inflammation, while 100 percent reported improved pain control and mental outlook, new research shows.

15 Apr 2013

Study: Transcendental meditation reduces posttraumatic stress in African refugees

A significant percentage of veterans returning from wars exhibit symptoms of posttraumatic stress (PTS). This is now recognized as a serious health problem, but what about the victims of such violence? Refugees live with the constant reminder of what war has done to their lives and those of their families.

9 Apr 2013

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

Free online sleep disorders guide for all professionals in primary care

The National Sleep Foundation is pleased to announce the launch of a comprehensive free online sleep disorders resource for all professionals in primary care. The "Sleep Disorders" guide is the updated web version of Dr. Peter Hauri's book, The Sleep Disorders, first published in 1977.

3 Apr 2013

Racial disparties in autism treatment

The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.

29 Mar 2013

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences, Inc. today announced that a Phase IIb clinical trial to evaluate elagolix for the treatment of uterine fibroids has been initiated.

27 Mar 2013

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

VIVUS, Inc. announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight loss could lead to significant improvements in Medicare spending by reversing or reducing significant health consequences such as type 2 diabetes, hypertension and dyslipidemia in obese or overweight patients.

25 Mar 2013

Alarming report on persistent side effects of antidepressant drugs published online

An alarming report from patient online websites on persistent side effects of antidepressant drugs has been published in one of the last issue of Psychotherapy and Psychosomatics by investigators from the University of Bologna and North America.

21 Mar 2013

Insomnia News and Research

Latest Insomnia News and Research

Addressing sleep hygiene prior to CPAP initiation may help improve adherence

Study shows association between diet, sleepiness and alertness

Restless legs syndrome and insomnia: a possible explanation

New report finds sharp increase in emergency department visits involving adverse reactions to zolpidem

Cognitive training improves insomnia sleep quality

Hostility linked to poor sleep quality

Phase IIb Aviator study demonstrates high SVR rates against genotype 1 HCV

Sucampo's supplemental new drug application for AMITIZA gets FDA approval

New data on Enanta's lead HCV protease inhibitor to be presented at International Liver Congress

Gilead Sciences to present results from four Phase 3 clinical trials at International Liver Congress 2013

Researchers suggest two days of staging at moderate altitude reduces acute mountain sickness

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

New research shows effects of long-term use of opioid therapy

Study: Transcendental meditation reduces posttraumatic stress in African refugees

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Free online sleep disorders guide for all professionals in primary care

Racial disparties in autism treatment

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

Alarming report on persistent side effects of antidepressant drugs published online

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Insomnia News and Research

Latest Insomnia News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in